BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17118349)

  • 1. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Survival of Leishmania major Depends on Uptake and Degradation of Extracellular Matrix Glycosaminoglycans by Macrophages.
    Naderer T; Heng J; Saunders EC; Kloehn J; Rupasinghe TW; Brown TJ; McConville MJ
    PLoS Pathog; 2015 Sep; 11(9):e1005136. PubMed ID: 26334531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ-Dependent Recruitment of CD4(+) T Cells and Macrophages Contributes to Pathogenesis During Leishmania amazonensis Infection.
    Carneiro MB; Lopes ME; Vaz LG; Sousa LM; dos Santos LM; de Souza CC; Campos AC; Gomes DA; Gonçalves R; Tafuri WL; Vieira LQ
    J Interferon Cytokine Res; 2015 Dec; 35(12):935-47. PubMed ID: 26401717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps.
    Rodríguez-Sosa M; Rosas LE; David JR; Bojalil R; Satoskar AR; Terrazas LI
    Infect Immun; 2003 Mar; 71(3):1247-54. PubMed ID: 12595439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.
    Woelbing F; Kostka SL; Moelle K; Belkaid Y; Sunderkoetter C; Verbeek S; Waisman A; Nigg AP; Knop J; Udey MC; von Stebut E
    J Exp Med; 2006 Jan; 203(1):177-88. PubMed ID: 16418399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Phenolic Fraction (TPF) from Extra Virgin Olive Oil: Induction of apoptotic-like cell death in Leishmania spp. promastigotes and in vivo potential of therapeutic immunomodulation.
    Karampetsou K; Koutsoni OS; Gogou G; Angelis A; Skaltsounis LA; Dotsika E
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008968. PubMed ID: 33428610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR activation induces M1 macrophage polarization via cPLA₂-COX-2 inhibition, activating ROS production against Leishmania mexicana.
    Díaz-Gandarilla JA; Osorio-Trujillo C; Hernández-Ramírez VI; Talamás-Rohana P
    Biomed Res Int; 2013; 2013():215283. PubMed ID: 23555077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major.
    Kropf P; Freudenberg MA; Modolell M; Price HP; Herath S; Antoniazi S; Galanos C; Smith DF; Müller I
    Infect Immun; 2004 Apr; 72(4):1920-8. PubMed ID: 15039311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide production by Peromyscus yucatanicus (Rodentia) infected with Leishmania (Leishmania) mexicana.
    Loría-Cervera EN; Sosa-Bibiano EI; Villanueva-Lizama LE; Van Wynsberghe NR; Canto-Lara SB; Batún-Cutz JL; Andrade-Narváez FJ
    Mem Inst Oswaldo Cruz; 2013 Apr; 108(2):172-7. PubMed ID: 23579796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of Leishmania major infection: Powerful synergistic and multifunctional effects.
    Keyhani A; Sharifi I; Salarkia E; Khosravi A; Tavakoli Oliaee R; Babaei Z; Ghasemi Nejad Almani P; Hassanzadeh S; Kheirandish R; Mostafavi M; Hakimi Parizi M; Alahdin S; Sharifi F; Dabiri S; Shamsi Meymandi S; Khamesipour A; Jafarzadeh A; Bamorovat M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108274. PubMed ID: 34688150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro.
    Reiling L; Chrobak M; Schmetz C; Clos J
    Mol Microbiol; 2010 Jun; 76(5):1175-90. PubMed ID: 20345655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The β-Carboline Harmine Has a Protective Immunomodulatory Role in Nonhealing Cutaneous Leishmaniasis.
    Peyvandi S; Lan Q; Chabloz A; Prével F; La Torre YH; Ives A; Tacchini-Cottier F
    J Invest Dermatol; 2024 Apr; 144(4):862-873.e4. PubMed ID: 37852357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis.
    Gomes CM; Goto H; Ribeiro Da Matta VL; Laurenti MD; Gidlund M; Corbett CE
    Int J Exp Pathol; 2000 Aug; 81(4):249-55. PubMed ID: 10971746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts as host cells in latent leishmaniosis.
    Bogdan C; Donhauser N; Döring R; Röllinghoff M; Diefenbach A; Rittig MG
    J Exp Med; 2000 Jun; 191(12):2121-30. PubMed ID: 10859337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana.
    Kovářová J; Pountain AW; Wildridge D; Weidt S; Bringaud F; Burchmore RJS; Achcar F; Barrett MP
    PLoS Pathog; 2018 Mar; 14(3):e1006953. PubMed ID: 29554142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulation by Taenia crassiceps and its antigens.
    Peón AN; Espinoza-Jiménez A; Terrazas LI
    Biomed Res Int; 2013; 2013():498583. PubMed ID: 23484125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis.
    Delorenzi JC; Freire-de-Lima L; Gattass CR; de Andrade Costa D; He L; Kuehne ME; Saraiva EM
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2111-5. PubMed ID: 12069962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of murine OX40L-murine IgG1(MM1) fusion protein on immunogenicity against L. mexicana infection in BALB/c mice.
    Rezvan H; Ali SA; Hamoon Navard S; Rees R
    Comp Immunol Microbiol Infect Dis; 2023 Aug; 99():102011. PubMed ID: 37393646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A
    Inêz-Ferreira TM; Mendoza L; Vilela R; Andrade HM; Haddad JP; Nunes FF; Gondim IM; Guimarães TM; de Toledo VP
    Heliyon; 2017 Mar; 3(3):e00278. PubMed ID: 28393124
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Volpedo G; Oljuskin T; Cox B; Mercado Y; Askwith C; Azodi N; Bernier M; Nakhasi HL; Gannavaram S; Satoskar AR
    iScience; 2023 Dec; 26(12):108502. PubMed ID: 38125023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.